Advanced Search

Journal of Traditional Chinese Medicine >

2025 , Vol. 45 >Issue 6: 1414 - 1422

DOI: https://doi.org/10.19852/j.cnki.jtcm.2025.06.019

Original Articles

Adjuvant therapy with Traditional Chinese Medicine and glycemic control in patients with type 2 diabetes mellitus: a retrospective cohort study

  • Chang SHANG ,
  • Ping LIU ,
  • Junge HAN ,
  • Shuanghui ZENG ,
  • Yue WANG ,
  • Mei HAN ,
  • Luying SUN
Expand
  • 1 Department of Nephropathy and Endocrine, Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing 100010, China
    2 Integrated Chinese and Western Medicine Metabolic Disease Research Center, Fangshan Hospital, Beijing University of Chinese Medicine, Beijing 102400, China
    3 Center for Evidence-Based Chinese Medicine, Beijing University of Chinese Medicine, Beijing 102488, China
SHANG Chang and LIU Ping are co-first authors and contributed equally to this work

Received date: 2024-11-25

  Accepted date: 2025-03-20

  Online published: 2025-11-24

Supported by

Industry-University-Research Collaborative Project: the Clinical and Basic Research on Liuzi Yangshen Formula in Preventing and Treating Renal Tubular Injury(HX-DZM-202501)

Fold

Abstract

OBJECTIVE: To explore the association between adjuvant therapy with Traditional Chinese Medicine (TCM) and glycemic control in patients with type 2 diabetes mellitus (T2DM) in the real world.

METHODS: In this retrospective cohort study, we consecutively collected medical records of T2DM patients enrolled in the Metabolic Management Center (MMC) from October 2021 to April 2024. Patients were divided into two groups based on the presence or absence of a TCM prescription within 6 months after enrollment in MMC management. Propensity score matching (PSM) was used to balance the differences in covariates between the two groups. The independent efficacy of adjuvant TCM therapy on glycemic control was assessed by univariate and multivariate logistic regression, and then further determined by subgroup analysis.

RESULTS: A total of 580 patients were included, with 441 patients (76.0%) receiving TCM treatment. Before PSM, multivariable logistic regression revealed that adjuvant TCM therapy was significantly associated with a lower incidence of poor glycemic control [odds ratio (OR) = 0.47, 95% confidence interval (CI) (0.30, 0.73)]. After PSM, weighted regression analysis further confirmed this inverse association [OR = 0.60; 95% CI (0.39, 0.92)]. In addition, patients treated with Chinese herbal medicine (CHM) alone [OR = 0.45; 95% CI (0.27, 0.75)], non-drug therapy (NDT) alone [OR = 0.56; 95% CI (0.32, 0.99)], and CHM + NDT [OR = 0.43; 95% CI (0.25, 0.74)] all exhibited a reduced incidence of poor glycemic control compared with those who did not receive TCM treatment.

CONCLUSION: The adjuvant TCM therapy is beneficial for achieving optimal glycemic control, suggesting that adjuvant TCM therapy may be embraced as a viable glycemic management approach for T2DM patients with poor glycemic control.

Key words： diabetes mellitus, type 2; medicine, Chinese traditional; drugs, Chinese herbal; glycemic control; metabolic management center

Cite this article

Chang SHANG , Ping LIU , Junge HAN , Shuanghui ZENG , Yue WANG , Mei HAN , Luying SUN . Adjuvant therapy with Traditional Chinese Medicine and glycemic control in patients with type 2 diabetes mellitus: a retrospective cohort study[J]. Journal of Traditional Chinese Medicine, 2025 , 45(6) : 1414 -1422 . DOI: 10.19852/j.cnki.jtcm.2025.06.019

References

1. Ahmad E, Lim S, Lamptey R, Webb DR, Davies MJ. Type 2 diabetes. Lancet 2022; 400: 1803-20.
2. International Diabetes Federation. IDF Diabetes Atlas, 10th edn online, 2021-12-06, cited 2024-06-07: 5. Available from URL https://wwwdiabetesatlasorg.
3. Zheng Y, Ley SH, Hu FB. Global aetiology and epidemiology of type 2 diabetes mellitus and its complications. Nat Rev Endocrinol 2018; 14: 88-98.
4. Tu WJ, Xue Y, Nie D. The prevalence and treatment of diabetes in China from 2013 to 2018. JAMA 2022; 327: 1706.
5. Zhang Y, Wang W, Ning G. Metabolic management center: an innovation project for the management of metabolic diseases and complications in China. J Diabetes 2019; 11: 11-13.
6. Hu J, Zhang F, Li XM, et al. Practice and benefit of national standardized management of type 2 diabetes in Yulin city. Xi'an Jiao Tong Da Xue Xue Bao (Yi Xue Ban) 2023; 44: 836-40.
7. Chen YK, Liu TT, Teia FKF, Xie MZ. Exploring the underlying mechanisms of obesity and diabetes and the potential of Traditional Chinese Medicine: an overview of the literature. Front Endocrinol (Lausanne) 2023; 14: 1218880.
8. Tan Y, Liu S, Huang M, et al. Efficacy and safety of Gegen Qinlian decoction in the treatment of type II diabetes mellitus: a systematic review and Meta-analysis of randomized clinical trials. Front Endocrinol (Lausanne) 2023; 14: 1316269.
9. Zhang Z, Leng Y, Fu X, et al. The efficacy and safety of dachaihu decoction in the treatment of type 2 diabetes mellitus: a systematic review and Meta-analysis. Front Pharmacol 2022; 13: 918681.
10. Amatto PPG, Chaves L, Braga GG, Carmona F, Pereira AMS. Effect of Crocus sativus L. (saffron) and crocin in the treatment of patients with type-2 diabetes mellitus: a systematic review and Meta-analysis. J Ethnopharmacol 2024; 319: 117255.
11. Hong KF, Liu PY, Zhang W, Gui DK, Xu YH. The efficacy and safety of astragalus as an adjuvant treatment for type 2 diabetes mellitus: a systematic review and Meta-analysis. J Integr Complement Med 2024; 30: 11-24.
12. Wang Y, Xu GN, Wan RH, et al. Acupuncture in treating obesity combined with type 2 diabetes mellitus: a systematic review and Meta-analysis of randomized controlled clinical trials. Complement Ther Clin Pract 2022; 49: 101658.
13. Franklin JM, Pawar A, Martin D, et al. Nonrandomized real-world evidence to support regulatory decision making: process for a randomized trial replication project. Clin Pharmacol Ther 2020; 107: 817-26.
14. Song S, Yanhong Z, Hongyang G, et al. Effectiveness of acupoint application of Xiaozhong Zhitong Tie on diarrhea in patients: a retrospective cohort study in China. J Tradit Chin Med 2023; 43: 809-14.
15. Zhou Q, Liu J, Xin L, et al. Association between Traditional Chinese Medicine and osteoarthritis outcome: a 5-year matched cohort study. Heliyon 2024; 10: e26289.
16. American Diabetes Association Professional Practice C. 6. Glycemic targets: standards of medical care in diabetes-2022. Diabetes Care 2022; 45: S83-96.
17. Leng Y, Zhou X, Xie Z, et al. Efficacy and safety of Chinese herbal medicine on blood glucose fluctuations in patients with type 2 diabetes mellitus: a protocol of systematic review and Meta-analysis Medicine (Baltimore) 2020; 99: e21904.
18. Ahmadi S, Rafiey H, Sajjadi H, et al. Trend and pattern of using herbal medicines among people who are aware of their diabetes mellitus: results from National STEPs surveys in 2005 to 2011 in Iran. J Diabetes Metab Disord 2021; 20: 1319-25.
19. Ryuk JA, Lixia M, Cao S, Ko BS, Park S. Efficacy and safety of Gegen Qinlian decoction for normalizing hyperglycemia in diabetic patients: a systematic review and Meta-analysis of randomized clinical trials. Complement Ther Med 2017; 33: 6-13.
20. Vuksan V, Xu ZZ, Jovanovski E, et al. Efficacy and safety of American ginseng (Panax quinquefolius L.) extract on glycemic control and cardiovascular risk factors in individuals with type 2 diabetes: a double-blind, randomized, cross-over clinical trial. Eur J Nutr 2019; 58: 1237-45.
21. Yang L, Yao D, Yang H, et al. Puerarin protects pancreatic beta-cells in obese diabetic mice via activation of GLP-1R signaling. Mol Endocrinol 2016; 30: 361-71.
22. Li X, Geng-Ji JJ, Quan YY, et al. Role of potential bioactive metabolites from Traditional Chinese Medicine for type 2 diabetes mellitus: an overview. Front Pharmacol 2022; 13: 1023713.
23. Zhu Z, Yu M, Xu M, et al. Baicalin suppresses macrophage JNK-mediated adipose tissue inflammation to mitigate insulin resistance in obesity. J Ethnopharmacol 2024; 332: 118355.
24. Zhang X, Jia L, Ma Q, et al. Astragalus polysaccharide modulates the gut microbiota and metabolites of patients with type 2 diabetes in an in vitro fermentation model. Nutrients 2024; 16: 1698.
25. Liu J, Yao C, Wang Y, Zhao J, Luo H. Non-drug interventions of Traditional Chinese Medicine in preventing type 2 diabetes: a review. Chin Med 2023; 18: 151.
26. Chen C, Liu J, Sun M, Liu W, Han J, Wang H. Acupuncture for type 2 diabetes mellitus: a systematic review and Meta-analysis of randomized controlled trials. Complement Ther Clin Pract 2019; 36: 100-12.
27. Chao M, Wang C, Dong X, Ding M. The effects of Tai Chi on type 2 diabetes mellitus: a Meta-analysis. J Diabetes Res 2018; 2018: 7350567.
28. Wang XZ, Jin FY, Wang XD. The effects of Tai Chi on glucose and lipid metabolism in patients with diabetes mellitus: a Meta-analysis. Complement Ther Med 2022; 71: 102871.
29. Wang Y, Yan J, Zhang P, Yang P, Zhang W, Lu M. Tai Chi program to improve glucose control and quality of life for the elderly with type 2 diabetes: a Meta-analysis. Inquiry 2022; 59: 469580211067934.
30. Zhang Y, Lin Y, Zhang J, et al. Association between insomnia and type 2 diabetes mellitus in Han Chinese individuals in Shandong province, China. Sleep Breath 2019; 23: 349-54.
31. Sommers T, Mitsuhashi S, Singh P, et al. Prevalence of chronic constipation and chronic diarrhea in diabetic individuals in the United States. Am J Gastroenterol 2019; 114: 135-42.
32. Ding C, Zhang J, Lau ESH, et al. Gender differences in the associations between insomnia and glycemic control in patients with type 2 diabetes: a cross-sectional study. Sleep 2019; 42: zsz014.
33. Suarez-Torres I, Garcia-Garcia F, Morales-Romero J, et al. Poor quality of sleep in Mexican patients with type 2 diabetes and its association with lack of glycemic control. Prim Care Diabetes 2023; 17: 155-60.
34. Sondrup N, Termannsen AD, Eriksen JN, et al. Effects of sleep manipulation on markers of insulin sensitivity: a systematic review and Meta-analysis of randomized controlled trials. Sleep Med Rev 2022; 62: 101594.
35. Maloney A, Kanaley JA. Short sleep duration disrupts glucose metabolism: can exercise turn back the clock? Exerc Sport Sci Rev 2024; 52: 77-86.
36. Wei L, Ji L, Miao Y, et al. Constipation in DM are associated with both poor glycemic control and diabetic complications: current status and future directions. Biomed Pharmacother 2023; 165: 115202.
37. Su Q, Wang L, Yu H, Li H, Zou D, Ni X. Chinese herbal medicine and acupuncture for insomnia in stroke patients: a systematic review and Meta-analysis of randomised controlled trials. Sleep Med 2024; 120: 65-84.
38. Yan L, Liu H, Yan R, Tan L, Tan J, Lei Y. Effect of Traditional Chinese Medicine external therapy for functional constipation: a Meta-analysis. Am J Transl Res 2023; 15: 13-26.
Options
Outlines

/

〈 〉